Increased Oversight of US Biomedical Research Funding Conducted in China.
This law mandates greater scrutiny over how federal taxpayer dollars are spent on biomedical research performed in China. It requires an annual report to Congress detailing the purpose, costs, and security risks of every funded project. The goal is to ensure public funds are used responsibly and critical health research remains secure.
Key points
Requires annual reporting on all US federally-funded biomedical research projects conducted in China.
Reports must detail project costs, purpose, location, and any affiliation with Chinese military or security agencies.
Increases transparency in public spending and enhances security measures for research, especially involving potential pandemic pathogens.
Expired
Citizen Poll